Medigene AG

Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term

21 May 2024 03:00:00 By Nasdaq GlobeNewswire

Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS

15 May 2024 08:00:00 By Nasdaq GlobeNewswire

Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise

14 May 2024 06:30:00 By Nasdaq GlobeNewswire

Medigene to Present at Upcoming Conferences

07 May 2024 08:00:00 By Nasdaq GlobeNewswire

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell Receptor

02 May 2024 03:30:00 By Nasdaq GlobeNewswire

Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein

02 May 2024 01:30:00 By Nasdaq GlobeNewswire

Medigene AG reports Financial Results and Business Update for Q1 2024

26 Apr 2024 02:00:00 By Nasdaq GlobeNewswire

Medigene presents streamlined 6-day, high stemness TCR-T therapy production process

25 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Medigene to Present at Upcoming Scientific Conferences

17 Apr 2024 05:00:00 By Nasdaq GlobeNewswire

Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024

08 Apr 2024 01:00:00 By Nasdaq GlobeNewswire

Medigene AG Secures European Patent for its iM-TCR Technology

04 Apr 2024 04:00:00 By Nasdaq GlobeNewswire

Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update

28 Mar 2024 01:30:00 By Nasdaq GlobeNewswire

Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

19 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Medigene AG to report full year 2023 financial results on March 28, 2024

18 Mar 2024 09:00:00 By Nasdaq GlobeNewswire

Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Protein with a Poster Presentation at AACR 2024 Annual Meeting

06 Mar 2024 04:00:00 By Nasdaq GlobeNewswire

Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo

04 Mar 2024 01:00:00 By Nasdaq GlobeNewswire

Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapies

29 Feb 2024 05:00:00 By Nasdaq GlobeNewswire

Medigene to Present at Upcoming Conferences

19 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid Tumors

12 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference

19 Dec 2023 07:00:00 By Nasdaq GlobeNewswire